About
Elias A. Zerhouni, M.D., has served as President and Vice Chairman of the Board of OPKO Health, Inc., a medical test and medication company, since May 2022. He was chairman and co-founder of ModeX Therapeutics Inc., a biotechnology company focused on multi-specific immune therapies for cancer and viral diseases, from October 2020 until its acquisition by OPKO in May 2022.
Dr. Zerhouni, a physician, scientist and world-renowned leader in radiology research, is widely viewed as one of the leading authorities in the United States on emerging trends and issues in medicine and medical care.
Roles
Danaher Corp.
Independent Director · Current role
2009–present
Sanofi S.A.
President, Global Research & Development · A global pharmaceutical company.
2011 – June 2018
Zerhouni Holdings
Chairman and President · Provided advisory and consulting services to various non-profit and other organizations.
2008 – 2011
National Institutes of Health
Director
2002 – 2008
Johns Hopkins School of Medicine
Chair, Russell H. Morgan Department of Radiology and Radiological Sciences; Vice Dean for Research; Executive Vice Dean
1996 – 2002
External Roles
OPKO Health, Inc.
President and Vice Chairman of the Board
May 2022 – present
Director Compensation
FY 2025
Fees earned or paid in cash
Not disclosed